Healthcare & Pharmaceutical

Dutko Grayling provides policy analysis & strategic counsel to leaders in the hospital, pharmaceutical, biotechnology & health plan sectors, as well as national consumer groups. We offer a bi-partisan approach to legislative and regulatory initiatives and have represented clients in a number of areas, including the passage, enactment & implementation of the landmark Medicare Modernization Act of 2003. Our ability to interact with key health care leaders on the Hill, as well as the decision-makers at the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA) & other government agencies allows us to provide a comprehensive benefit to our clients. We have also had the opportunity to represent a number of industry-wide coalitions, ranging from the Power Mobility Coalition to the Senior Care Pharmacy Alliance.